Diego Scheggia

Dr. Diego Scheggia

Department of Pharmacological and Biomolecular Sciences, University of Milan, 20133 Milan, Italy

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2019 in Current Biology
Verified
Journal Article
Closed access
VFValentina Ferretti
Valentina Ferretti
FMFederica Maltese
Federica Maltese
GCGabriella Contarini
Gabriella Contarini
MNMarco Nigro
Marco Nigro
ABAlessandra Bonavia
Alessandra Bonavia
FPFrancesco Papaleo
Francesco Papaleo

16 December 2019 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
Diego ScheggiaDiego Scheggia
Diego Scheggia
FMFrancesca Managò
Francesca Managò
FMFederica Maltese
Federica Maltese
SBStefania Bruni
Stefania Bruni
MNMarco Nigro
Marco Nigro
FPFrancesco Papaleo
Francesco Papaleo

4 November 2013 in Neuropsychopharmacology
Verified
Journal Article
Closed access
HHHuiping Huang
Huiping Huang
CMCaterina Michetti
Caterina Michetti
MBMarta Busnelli
Marta Busnelli
FMFrancesca Managò
Francesca Managò
SSSara Sannino
Sara Sannino
FPFrancesco Papaleo
Francesco Papaleo

1 October 2018 in Cell
Verified
Journal Article
Open access
DTDavid Terburg
David Terburg
Diego ScheggiaDiego Scheggia
Diego Scheggia
RRRodrigo Triana del Rio
Rodrigo Triana del Rio
FKFloris Klumpers
Floris Klumpers
ACAlexandru Cristian Ciobanu
Alexandru Cristian Ciobanu
JHJack van Honk
Jack van Honk
Rodent research delineates how the basolateral amygdala (BLA) and central amygdala (CeA) control defensive behaviors, but translation of these findings to humans is needed. Here, we compare humans with natural-selective bilateral BLA lesions to rats with a chemogenetically silenced BLA. We find, across species, an essential role for the BLA in the selection of active escape over passive freezing during exposure to imminent yet escapable threat (Timm). In response to Timm, BLA-damaged humans showed increased startle potentiation and BLA-silenced rats demonstrated increased startle potentiation, freezing, and reduced escape behavior as compared to controls. Neuroimaging in humans suggested that the BLA reduces passive defensive responses by inhibiting the brainstem via the CeA. Indeed, Timm conditioning potentiated BLA projections onto an inhibitory CeA pathway, and pharmacological activation of this pathway rescued deficient Timm responses in BLA-silenced rats. Our data reveal how the BLA, via the CeA, adaptively regulates escape behavior from imminent threat and that this mechanism is evolutionary conserved across rodents and humans.

2 September 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
NGNataliya Gorinski
Nataliya Gorinski
MBMonika Bijata
Monika Bijata
SPSonal Prasad
Sonal Prasad
AWAlexander Wirth
Alexander Wirth
DGDalia Abdel Galil
Dalia Abdel Galil
EPEvgeni Ponimaskin
Evgeni Ponimaskin
The serotonergic system and in particular serotonin 1A receptor (5-HT1AR) are implicated in major depressive disorder (MDD). Here we demonstrated that 5-HT1AR is palmitoylated in human and rodent brains, and identified ZDHHC21 as a major palmitoyl acyltransferase, whose depletion reduced palmitoylation and consequently signaling functions of 5-HT1AR. Two rodent models for depression-like behavior show reduced brain ZDHHC21 expression and attenuated 5-HT1AR palmitoylation. Moreover, selective knock-down of ZDHHC21 in the murine forebrain induced depression-like behavior. We also identified the microRNA miR-30e as a negative regulator of Zdhhc21 expression. Through analysis of the post-mortem brain samples in individuals with MDD that died by suicide we find that miR-30e expression is increased, while ZDHHC21 expression, as well as palmitoylation of 5-HT1AR, are reduced within the prefrontal cortex. Our study suggests that downregulation of 5-HT1AR palmitoylation is a mechanism involved in depression, making the restoration of 5-HT1AR palmitoylation a promising clinical strategy for the treatment of MDD.

1 August 2016 in Cell Reports
Verified
Journal Article
Open access
FMFrancesca Managò
Francesca Managò
MMMaddalena Mereu
Maddalena Mereu
SMSurjeet Mastwal
Surjeet Mastwal
RMRosa Mastrogiacomo
Rosa Mastrogiacomo
Diego ScheggiaDiego Scheggia
Diego Scheggia
FPFrancesco Papaleo
Francesco Papaleo
Human genetic studies have recently suggested that the postsynaptic activity-regulated cytoskeleton-associated protein (Arc) complex is a convergence signal for several genes implicated in schizophrenia. However, the functional significance of Arc in schizophrenia-related neurobehavioral phenotypes and brain circuits is unclear. Here, we find that, consistent with schizophrenia-related phenotypes, disruption of Arc in mice produces deficits in sensorimotor gating, cognitive functions, social behaviors, and amphetamine-induced psychomotor responses. Furthermore, genetic disruption of Arc leads to concomitant hypoactive mesocortical and hyperactive mesostriatal dopamine pathways. Application of a D1 agonist to the prefrontal cortex or a D2 antagonist in the ventral striatum rescues Arc-dependent cognitive or psychomotor abnormalities, respectively. Our findings demonstrate a role for Arc in the regulation of dopaminergic neurotransmission and related behaviors. The results also provide initial biological support implicating Arc in dopaminergic and behavioral abnormalities related to schizophrenia.